AI-Enabled Wound Analysis Market Report 2026

The artificial intelligence (AI)-enabled wound analysis market size has grown rapidly in recent years. It will grow from $1.17 billion in 2025 to $1.34 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to rising prevalence of chronic wounds and diabetic ulcers, limited accuracy in manual wound assessment, increasing hospital workload in wound care management, growing adoption of digital imaging in clinical settings, need for standardized wound documentation practices.

The artificial intelligence (AI)-enabled wound analysis market size is expected to see rapid growth in the next few years. It will grow to $2.28 billion by 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to expansion of remote patient monitoring and home healthcare, increasing adoption of ai-powered diagnostic imaging tools, growing integration of telemedicine in wound management, rising demand for predictive clinical analytics in treatment planning, advancements in computer vision for medical image analysis. Major trends in the forecast period include remote wound monitoring and telehealth integration expansion, ai-based wound severity grading and classification systems, rising adoption of automated chronic wound management platforms, integration of clinical decision support systems in wound care workflows, increasing use of predictive healing trajectory analytics.

The increasing adoption of personalized medicine approaches is expected to drive the growth of the artificial intelligence (AI)-enabled wound analysis market in the coming years. Personalized medicine refers to a medical approach that customizes treatment strategies based on individual patient characteristics, including genetic profile, biomarker status, lifestyle, and disease-specific factors, with the aim of improving therapeutic effectiveness and minimizing adverse effects. A key factor driving the rising adoption of personalized medicine approaches is the growing integration of genomic insights into clinical practice, as advancements in genetic profiling enable healthcare providers to more precisely identify disease predispositions and treatment responsiveness, thereby supporting more targeted and effective therapeutic decisions. AI-enabled wound analysis supports personalized medicine by assessing individual wound characteristics (size, depth, tissue type, infection risk) in real time, enabling clinicians to tailor treatment plans specifically to each patient’s wound profile, improving healing outcomes and reducing complications. For instance, in February 2024, according to a report by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, more than one-third of new drug approvals by the U. S. Food and Drug Administration have consistently been personalized therapies for four consecutive years through 2023, with approvals in 2023 including 16 rare disease treatments (up from six in 2022), along with seven oncology drugs and three targeting other conditions. Therefore, the increasing adoption of personalized medicine approaches is driving the growth of the artificial intelligence (AI)-enabled wound analysis market.

Leading companies operating in the artificial intelligence (AI)-enabled wound analysis market are focusing on developing advanced solutions such as AI-driven digital wound assessment platforms to enhance accuracy, standardize documentation, improve clinical decision-making, and accelerate wound healing across home health, ambulatory, acute, and skilled nursing settings. AI-driven digital wound assessment platforms use advanced imaging, generative AI algorithms, and interoperability standards to provide unbiased diagnostics, precise measurements, and actionable clinical insights. For example, in October 2024, Swift Medical, a Canada-based digital wound care company, launched its Skin & Wound 2 platform, an AI-based digital wound care solution designed to support patient assessments across multiple care settings. The platform incorporates FHIR standards, integrates with EMR systems like Homecare Homebase, and leverages AI to ensure accurate and equitable wound evaluations across all skin tones. Skin & Wound 2 has been deployed in over 4,800 facilities, supporting more than 21,000 clinicians and enabling over 600,000 wound care evaluations in a single month, aiming to improve healing rates and enhance patient outcomes.

In April 2023, MolecuLight Corp., a US-based provider of point-of-care fluorescence imaging for real-time detection of bacterial load in wounds, partnered with Perceptive Solutions Inc. to integrate its MolecuLightDX device with the WoundZoom cloud-based wound management platform. Through this partnership, the companies aim to advance the AI-enabled wound analysis market by offering clinicians a unified solution for wound imaging, digital measurement, and comprehensive cloud-based documentation. The integrated platform supports automated image and measurement uploads, synchronization across multiple devices, and advanced analytics to enhance clinical decision-making, operational efficiency, and patient outcomes. Perceptive Solutions is a US-based healthcare SaaS company providing mobile and cloud applications for wound assessment, documentation, and management, designed to streamline workflows and support evidence-based care.

Major companies operating in the artificial intelligence (AI)-enabled wound analysis market are Smith + Nephew plc, Healthy. io Ltd., Spectral AI Inc., Swift Medical Inc., cureVision GmbH, ARANZ Medical Ltd., Entec Health Ltd., WoundVision LLC, eKare Inc., Intellicure LLC, MolecuLight Corp., Kent Imaging Inc., Mimosa Diagnostics Inc., CutoSense, WoundMatrix Inc., imito AG, KroniKare Pte Ltd., WoundZoom Inc., The Wound Pros Inc., Urgo Group.

North America was the dominating region in the artificial intelligence (AI)-enabled wound analysis market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the artificial intelligence (AI)-enabled wound analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial intelligence (AI)-enabled wound analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enabled wound analysis market consists of revenues earned by entities by providing services such as AI-based wound assessment services, digital wound imaging and documentation services, and remote wound monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enabled wound analysis market also includes sales of imaging devices, wound measurement cameras, 3D imaging systems, smartphones and tablets used for wound capture, sensors, and edge computing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.